Prospective Cohort Study to Determine Effectiveness of Telemedicine-based on Site Hepatitis C Management in Probation and Parole Office
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Jens Rosenau
- 入组人数
- 77
- 试验地点
- 2
- 主要终点
- HCV treatment uptake rate of HCV RNA positive participants
研究概览
简要总结
This prospective cohort study compares aims to determine the efficacy and effectiveness of telemedicine-supported on-site linkage to care and treatment in a community probation and parole office (P&P office) setting and compare the results with a historic control with referral to care. Research participants will be followed in the P&P office when they report to their officer during regularly scheduled appointments. Participants will receive treatment without having to travel to a specialist's office. The telemedicine visit will include a consultation with an experienced HCV provider such as a hepatologist or an advanced practice provider and a specialty pharmacist who will educate about and monitor HCV treatment. The UK specialty pharmacy will be available to participants and the HCV management team through a 24-hour support line. Participants will be treated per HCV guidelines and insurance preference.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 99 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clients who will be supervised in the probation and parole office for at least 5 months
- •History of hepatitis C
- •Able to obtain health insurance
- •Capacity to provide written, informed consent
- •Life expectancy >1 year
排除标准
- •Negative HCV RNA
- •Pregnant or breast-feeding
- •HIV or HBV co-infection
- •Liver cirrhosis with Child-Turcotte-Pugh score 6 or greater at baseline lab work
- •Subjects with impaired capacity to provide informed consent
结局指标
主要结局
HCV treatment uptake rate of HCV RNA positive participants
时间窗: 6 months
Percentage of treatment uptake among treatment eligible patients seen by a provider via telemedicine.
次要结局
- HCV treatment uptake rate(6 months)
- Determine visit adherence(6 months)
研究者
Jens Rosenau
Associate Professor
University of Kentucky
